+3.20%
Today
Loading 1D prices…
Company profile
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Sector
Health Care
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Exchange
NYSE
Display currency
USD
Location
IRVINE, CA, United States
Employees
16K
Fiscal year end
1231
CIK
1099800
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ISRGIntuitive Surgical Inc. Common Stock | $126.6B | $10.1B | +28.38% | $7.87 | +6.25% | Buy |
| STESTERIS plc (Ireland) Ordinary Shares | — | $5.9B | +13.18% | $7.93 | +1.87% | Buy |
| ZBHZimmer Biomet Holdings Inc. Common Stock | — | $8.2B | +8.57% | $3.55 | +3.26% | Unrated |
| SNNSmith & Nephew SNATS Inc. Common Stock | — | — | — | — | +2.09% | Unrated |
| ALGNAlign Technology Inc. Common Stock | — | $4.0B | +10.16% | $5.65 | +2.22% | Unrated |